Intraventricular lymphoplasmacyte-rich meningioma: a case report

Yu-Bo Wang1, Wen-Jun Wang, Song-Bai Xu

  • 1First Hospital of Jilin University, Department of Neurosurgery, Changchun, Jilin, P.R. China.

Turkish Neurosurgery
|December 3, 2014
PubMed

Insights

A rare intraventricular lymphoplasmacyte-rich meningioma (LPM) was surgically removed from a 37-year-old woman. Histology confirmed LPM, showing a positive Ki-67 proliferation marker, with no recurrence at follow-up.

Area of Science:

  • Neuro-oncology
  • Surgical Pathology

Background:

  • Lymphoplasmacyte-rich meningioma (LPM) is a rare variant of meningioma, with intraventricular occurrence being exceptionally infrequent.
  • Typically classified as World Health Organization (WHO) grade I (benign), LPMs are characterized by a high infiltrate of lymphocytes and plasma cells.

Observation:

  • A 37-year-old female presented with a generalized tonic-clonic seizure, leading to the discovery of an intraventricular mass via magnetic resonance imaging.
  • The mass exhibited features of partial mortification, significant peritumoral edema, and a rough surface.

Findings:

  • Surgical resection and subsequent histological analysis confirmed the diagnosis of LPM.
  • Despite the benign classification, the tumor tested positive for the proliferation marker Ki-67.
  • Post-operative imaging at 3 months showed no evidence of residual tumor or recurrence.

Implications:

  • This case highlights the importance of thorough histological examination, including proliferation markers, even in typically benign tumor variants.
  • The findings contribute to the understanding of intraventricular LPMs, emphasizing the need for careful surgical management and follow-up.
  • Further research may elucidate the clinical significance of Ki-67 positivity in LPMs.